Besides its potential roles as a central neuromodulator or a hypothalamic neurohormone, neurotensin (NT) may also have endocrine function in the anterior pituitary of mammals. We previously found that NT immunoreactivity is present in the secretory granules of gonadotropes and thyrotropes in both male and female rats, where its levels of expression are under the control of sex steroids. In this work, using immunocytochemistry and in situ hybridization, we have studied the postnatal development of NT-like immunoreactivity (NTir) and the mRNA encoding NT (mRNA-NT) in specific anterior pituitary cells of both male and female rats. NT expression starts after birth and displays an identical pattern in both sexes until sexual maturity, with mRNA-NT being detected from day 2 of postnatal life in thyrotropes localized in the central portion of the anterior lobe. This pattern of expression develops progressively throughout the 2nd and 3rd weeks in both sexes. By the beginning of the 3rd week, mRNA-NT can also be detected in gonadotropes localized in the periphery of the gland coinciding with a rise in serum estradiol concentrations in both sexes, and by day 21, mRNA-NT is extensively present in both the periphery and the central region. NTir is observed from days 5–6 in thyrotropes predominantly localized in the central portion of the anterior lobe, and by day 21, NTir is also detected in gonadotropes localized in the periphery of the gland. This pattern remains similar in both sexes until the time of puberty, when female rats start displaying plastic changes in NT expression according to the stage of the estrous cycle. These findings indicate that NT expression in the rat anterior pituitary is cell specific, and develops from birth to adulthood under the control of sex steroid hormones. In addition, preliminary data showing the presence of NT receptors in rat pituitary cells support the hypothesis of a paracrine or an autocrine role for this peptide within the pituitary.

Keywords:
Neurotensin, Gonadotropes, Thyrotropes, Gonadal steroids, Immunocytochemistry, Estrous cycle, Sex dimorphism
1.
Carraway R, Leeman SE: Characterization of radioimmunoassayable neurotensin in the rat. J Biol Chem 1976;251:7045–7052.
2.
Rostène W, Alexander MJ: Neurotensin and neuroendocrine regulation. Front Neuroendocrinol 1997;18:115–173.
3.
Tyler-McMahon BM, Boules M, Richelson E: Neurotensin: A peptide for the next millennium. Regul Pept 2000;93:125–136.
4.
Eckland DJ, Lightman SL: Neurotensin in hypothalamo-hypophyseal portal blood. Brain Res 1987;421:161–166.
5.
Watanobe H, Takebe K: In vivo release of neurotensin from the median eminence of ovariectomized estrogen-primed rats as estimated by push-pull perfusion: Correlation with luteinizing hormone and prolactin surges. Neuroendocrinology 1993;57:760–764.
6.
Vijayan E, Carraway R, Leeman SE, McCann SM: Physiological significance of neurotensin in pituitary glycoprotein hormone release as revealed by in vivo and in vitro studies with neurotensin antiserum. Neuroendocrinology 1994;60:157–164.
7.
Goedert M, Lightman SL, Emson PC: Neurotensin in the rat anterior pituitary: Effects of endocrinological manipulations. Brain Res 1984;299:160–163.
8.
O’Halloran DJ, Jones PM, Ghatei MA, Domin J, Bloom SR: The regulation of neuropeptide expression in rat anterior pituitary following chronic manipulation of estrogen status: A comparison between substance P, neuropeptide Y, neurotensin, and vasoactive intestinal peptide. Endocrinology 1990;127:1463–1469.
9.
Bello AR, Dubourg P, Kah O, Tramu G: Identification of neurotensin-immunoreactive cells in the anterior pituitary of normal and castrated rats. Neuroendocrinology 1992;55:714–723.
10.
Bello AR, Hernández G, González M, Reyes R, Negrín I, Marrero A, Sánchez-Criado JE, Tramu G, Alonso R: Immunoreactive neurotensin in gonadotropes and thyrotropes is regulated by sex steroid hormones in the female rat. J Neuroendocrinol 1999;11:785–794.
11.
Studler JM, Kitabgi P, Tramu G, Hervé D, Glowinski J, Tassin JP: Extensive colocalisation of neurotensin with dopamine in rat meso-cortico-frontal dopaminergic neurons. Neuropeptides 1988;11:95–100.
12.
Tramu G, Pillez A, Léonardelli J: An efficient method of antibody elutin for the successive or simultaneous location of two antigens by immunocytochemistry. J Histochem 1978;26:322–324.
13.
Alexander MJ, Kiraly ZJ, Leeman SE: Sexually dimorphic distribution of neurotensin/neuromedin N mRNA in the rat preoptic area. J Comp Neurol 1991;311:84–96.
14.
Ciofi P: Phenotypical segregation among female rat hypothalamic gonadotropin-releasing hormone neurons as revealed by the sexually dimorphic expression of cholecystokinin and neurotensin. Neuroscience 2000;99:133–147.
15.
Alexander MJ: Estrogen-regulated synthesis of neurotensin in neurosecretory cells of the hypothalamic arcuate nucleus in the female rat. Endocrinology 1993;133:1809–1816.
16.
Dohler KD, Wuttke W: Changes with age in levels of serum gonadotropins, prolactin, and gonadal steroids in prepubertal male and female rats. Endocrinology 1975;97:898–907.
17.
Merchenthaler I, López FJ, Lennard DE, Negro-Vilar A: Sexual differences in the distribution of neurons coexpressing galanin and luteinizing hormone-releasing hormone in the rat brain. Endocrinology 1991;129:1977–1986.
18.
Shen ES, Hardenburg JL, Meade EEH, Arey BJ, Merchenthaler I, López FJ: Estradiol induces galanin gene expression in the pituitary of the mouse in an estrogen receptor alpha-dependent manner. Endocrinology 1999;140:2628–2631.
19.
Bernal J, Núñez J: Thyroid hormones and brain development. Eur J Endocrinol 1995;133:390–398.
20.
Poddar R, Paul S, Chaudhuzy S, Sarkar PK: Regulation of actin and tubulin gene expression by thyroid hormone during rat brain development. Mol Brain Res 1996;35:111–118.
21.
Gohsh S, Rahaman SO, Sarkar PK: Regulation of neurofilament gene expression by thyroid hormone in the developing rat brain. Neuroreport 1999;10:2361–2365.
22.
Hara Y, Shiosaka S, Semba E, Sakanaka M, Inagaki S, Takagi H, Kawai Y, Takatsuki K, Matsuzaki T, Tohyama M: Ontogeny of the neurotensin-containing neuron system of the rat: Immunohistochemical analysis. I. Forebrain and diencephalon. J Comp Neurol 1982;208:177–195.
23.
Memo M, Castelleti L, Valwrio A, Missale C, Spano PF: Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary. J Neurochem 1986;47:1682–1688.
24.
Ross PC, Judd AM, MacLeod RM: The dynamics of arachidonic acid liberation and prolactin release: A comparison of thyrotropin-releasing hormone, angiotensin II, and neurotensin stimulation in perifused rat anterior pituitary cells. Endocrinology 1988;123:2445–2453.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.